Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus

Journal of Virology

Volumn 73, Issue 8, 1999, Pages 6953-6963

  Glenn, Mark ^a   Rainbow, Lucille ^a   Auradé, Frédéric ^a   Davison, Andrew ^b   Schulz, Thomas F ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b INSTITUTE OF VIROLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLUTATHIONE TRANSFERASE; LATENT MEMBRANE PROTEIN 1; PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; EPSTEIN BARR VIRUS; EXON; GENE; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LYMPHOMA; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENOME;

EID: 0032775720     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.8.6953-6963.1999     Document Type: Article

References (76)

1. Albrecht, J.-C., J. Nicholas, D. Biller, K. R. Cameron, B. Biesinger, C. Newman, S. Wittmann, M. A. Craxton, H. Coleman, B. Fleckenstein, and R. W. Honess. 1992. Primary structure of the herpesvirus saimiri genome. J. Virol. 66:5047-5058.
2. Ambroziak, J. A., D. J. Blackbourn, B. G. Herndier, R. G. Glogau, J. H. Gullett, A. R. McDonald, E. T. Lennette, and J. A. Levy. 1995. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 268:582-583.
3. Auradé, F., and T. Schulz. Unpublished data.
4. Beral, V. 1991. Epidemiology of Kaposi's sarcoma, p. 5-22. In V. Beral, H. W. Jaffe, and R. A. Weiss (ed.), Cancer, HIV, and AIDS, cancer surveys, vol. 10. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
5. Blasig, C., C. Zietz, B. Haar, F. Neipel, S. Esser, N. H. Brockmeyer, E. Tschachler, S. Colombini, B. Ensoli, and M. Stürzl. 1997. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J. Virol. 71:7963-7968.
6. Bolen, J. B. 1993. Nonreceptor tyrosine protein kinases. Oncogene 8:2025-2031.
7. Boshoff, C., D. Whitby, T. Hatzioannou, C. Fisher, J. van der Walt, A. Hatzakis, R. A. Weiss, and T. F. Schulz. 1995. Kaposi's sarcoma associated herpesvirus in HIV-negative Kaposi sarcoma. Lancet 345:1043-1044.
8. Boshoff, C., T. F. Schulz, M. M. Kennedy, A. K. Graham, C. Fisher, A. Thomas, J. O. McGee, R. A. Weiss, and J. J. O'Leary. 1995. Kaposi's sarcoma associated herpesvirus infects endothelial and spindle cells. Nat. Med. 1:1274-1278.
9. Buonaguro, F. M., M. L. Tornesello, E. Beth-Giraldo, A. Hatzakis, N. Mueller, R. Downing, B. Biryamwaho, S. D. Sempala, and G. Giraldo. 1996. Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int. J. Cancer 65:25-28.
10. Burkhardt, A. L., J. B. Bolen, E. Kieff, and R. Longnecker. 1992. An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. J. Virol. 66:5161-5167.
11. Calabrò, M. L., J. Sheldon, A. Favero, G. R. Simpson, J. R. Fiore, E. Gomes, G. Angarano, L. Chieco-Bianchi, and T. F. Schulz. 1998. Seroprevalence of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) in different regions of Italy. J. Hum. Virol. 1:207-213.
12. Cambier, J. C., C. M. Pleiman, and M. R. Clark. 1994. Signal transduction by the B cell antigen receptor and its coreceptors. Annu. Rev. Immunol. 12:457-486.
13. Cesarman, E., Y. Chang, P. S. Moore, J. W. Said, and D. M. Knowles. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332:1186-1191.
14. Chang, Y., E. Cesarman, M. S. Pessin, F. Lee, J. Culpepper, D. M. Knowles, and P. S. Moore. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869.
15. Chang, Y., J. Ziegler, H. Wabinga, E. Katangole-Mbidde, C. Boshoff, T. F. Schulz, D. Whitby, D. Maddalena, H. W. Jaffe, R. A. Weiss, and P. S. Moore. 1996. Kaposi's sarcoma-associated herpesvirus DNA sequences are present in African endemic and AIDS-associated Kaposi's sarcoma. Arch. Intern. Med. 156:202-204.
16. Cohen, J. I., J. M. Wang, and E. Kieff. 1989. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl. Acad. Sci. USA 86:9558-9562.
17. Cook, P. M., D. Whitby, M. L. Calabro, M. Luppi, D. N. Kakoola, H. Hjalgrim, K. Arioshi, B. Ensoli, A. J. Davison, T. F. Schulz, and the International Collaborative Group. 1999. Variability and evolution of Kaposi's Sarcoma-associated Herpesvirus in Europe and Africa. AIDS, in press.
18. Corbellino, M., L. Poirel, G. Bestetti, M. Pizzuto, J. T. Aubin, M. Capra, C. Bifulco, E. Berti, H. Agut, G. Rizzardini, M. Galli, and C. Parravicini. 1996. Restricted tissue distribution of extralesional Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi's sarcoma. AIDS Res. Hum. Retroviruses 12:651-657.
19. Davis, D. A., R. W. Humphrey, F. M. Newcomb, T. R. O'Brien, J. J. Goedert, S. E. Straus, and R. Yarchoan. 1997. Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells. J. Nat. Cancer Inst. 89:1868-1874.
20. Dawson, C. W., A. B. Rickinson, and L. S. Young. 1990. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 344:777-780.
21. Decker, L. L., P. Shankar, and G. Khan. 1996. The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J. Exp. Med. 184:283-288.
22. Devergne, O., E. Hatzivassiliou, K. M. Izumi, K. M. Kaye, M. F. Kleijnen, E. Kieff, and G. Mosialos. 1996. Association of TRAF1, TRAF2 and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-KB activation. Mol. Cell. Biol. 16:7098-7108.
23. Eliopoulos, A. G., S. M. S. Blake, J. E. Floettmann, M. Rowe, and L. S. Young. 1999. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2. J. Virol. 73:1023-1035.
24. Fennewald, S., V. van Santen, and E. Kieff. 1984. Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates it may encode a membrane protein. J. Virol. 51:411-419.
25. Fruehling, S., and R. Longnecker. 1997. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235:241-251.
26. Fruehling, S., S. Lee, R. Herrold, B. Frech, B. Laux, E. Kremmer, F. A. Grasser, and R. Longnecker. 1996. Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction. J. Virol. 70:6216-6226.
27. Gao, S. J., L. Kingsley, M. Li, W. Zheng, C. Parravicini, J. Ziegler, R. Newton, C. R. Rinaldo, A. Saah, J. Phair, R. Detels, Y. Chang, and P. S. Moore. 1996. Seroprevalence of KSHV antibodies among North Americans, Italians, and Ugandans with and without Kaposi's sarcoma. Nat. Med. 2:925-928.
28. Gao, S. J., C. Boshoff, S. Jayachandra, R. A. Weiss, Y. Chang, and P. S. Moore. 1997. KSHV orf K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 15:1979-1985.
29. Harrington, W. J., O. Bagasra, C. E. Sosa, L. E. Bobroski, M. Baum, X.-L. Wen, L. Cabral, G. E. Byrne, R. J. Pomerantz, and C. Wood. 1996. Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients. J. Infect. Dis. 174:1101-1105.
30. Huen, D. S., S. A. Henderson, D. Croom-Carter, and M. Rowe. 1995. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-KB and cell surface phenotype via two effector regions in its carboxyterminal cytoplasmic domain. Oncogene 10:549-560.
31. Kaye, K. M., K. M. Izumi, and E. Kieff. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 90:9150-9154.
32. Kedes, D. H., E. Operskalski, M. Busch, R. Kohn, J. Flood, and D. Ganem. 1996. The seroprevalence of human herpesvirus 8 (HHV 8): distribution of infection in Kaposi's sarcoma risk groups and evidence for sexual transmission. Nat. Med. 2:918-924.
33. Kieff, E. 1996. Epstein-Barr virus and its replication. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Virology. Lippincott-Raven, Philadelphia, Pa.
34. Kim, O.-J., and J. L. Yates. 1993. Mutants of Epstein-Barr virus with a selective marker disrupting the TP gene transform B cells and replicate normally in culture. J. Virol. 67:7634-7640.
35. Lagunoff, D., and D. Ganem. 1997. The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). Virology 236:147-154.
36. Lee, H., J. Guo, M. Li, J.-K. Choi, M. DeMaria, M. Rosenzweig, and J. U. Jung. 1998. Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Mol. Cell. Biol. 18:5219-5228.
37. Li, J. J., Y. Q. Huang, C. J. Cockerell, and A. E. Friedman-Kien. 1996. Localization of human herpes-like virus type 8 in vascular endothelial cells and perivascular spindle-shaped cells of Kaposi's sarcoma lesions by in situ hybridization. Am. J. Pathol. 148:1741-1748.
38. Longnecker, R., C. L. Miller, X.-Q. Miao, A. Marchini, and E. Kieff. 1992. The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro, and LMP2A is therefore nonessential. J. Virol. 66:6461-6469.
39. Longnecker, R., C. Miller, X. Miao, B. Tomkinson, and E. Kieff. 1993. The last seven transmembrane and carboxy terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein (LMP2A) are dispensable for lymphocyte infection and growth transformation in vitro. J. Virol. 67:2006-2013.
40. Longnecker, R., C. L. Miller, B. Tomkinson, X. Q. Miao, and E. Kieff. 1993. Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B. J. Virol. 67:5068-5074.
41. Mannick, J. B., J. I. Cohen, M. Birkenbach, A. Marchini, and E. Kieff. 1991. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J. Virol. 65:6826-6837.
42. Mayama, S., L. Cuevas, J. Sheldon, D. Smith, P. Okong, B. Silvel, and T. F. Schulz. 1998. Prevalence of Kaposi's sarcoma associated herpesvirus (human herpesvirus 8) in a young Ugandan population. Int. J. Cancer 77:817-820.
43. Mesri, E. A., E. Cesarman, L. Arvanitakis, S. Rafii, M. A. S. Moore, D. N. Posnett, D. M. Knowles, and A. S. Asch. 1996. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J. Exp. Med. 183:2385-2390.
44. Miller, C., A. Burkhardt, J. Lee, B. Stealy, R. Longnecker, and E. Kieff. 1995. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein tyrosine kinases. Immunity 2:155-166.
45. Miller, C., J. Lee, E. Kieff, and R. Longnecker. 1994. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin cross-linking. Proc. Natl. Acad. Sci. USA 91:772-776.
46. Miller, C. L., R. Longnecker, and E. Kieff. 1993. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. J. Virol. 67:3087-3094.
47. Miller, W. E., G. Mosialos, E. Kieff, and N. Raab-Trab. 1997. Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-KB activation. J. Virol. 71:586-594.
48. Moore, P. Personal communication.
49. Moore, P. S., and Y. Chang. 1995. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. New Engl. J. Med. 332:1181-1185.
50. Moore, P. S., C. Boshoff, R. A. Weiss, and Y. Chang. 1996. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274:1739-1744.
51. Mosialos, G., M. Birkenbach, T. VanArsdale, C. Ware, R. Yalamanchill, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-399.
52. Muralidhar, S., A. M. Pumfery, M. Hassani, M. R. Sadaie, N. Azumi, M. Kishishita, J. N. Brady, J. Doniger, P. Medveczky, and L. J. Rosenthal. 1998. Identification of Kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J. Virol. 72:4980-4988.
53. Neipel, F., J.-C. Albrecht, and B. Fleckenstein. 1997. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? J. Virol. 71:4187-4192.
54. Nicholas, J., V. Ruvolo, J. Zong, D. Ciufo, H.-G. Guo, M. S. Reitz, and G. S. Hayward. 1997. A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins. J. Virol. 71:1963-1974.
55. Nicholas, J., J. Zong, D. J. Alcendor, D. Ciufo, L. J. Poole, R. Y. Sarisky, C.-J. Chiou, X. Zhang, X. Wan, H.-G. Guo, M. S. Reitz, and G. S. Hayward. 1998. Novel organizational features, captured cellular genes and strain variability within the genome of KSHV/HHV8. Monogr. Natl. Cancer Inst. 23:79-88.
56. Rainbow, L., G. M. Platt, G. R. Simpson, R. Sarid, S.-J. Gao, H. Stoiber, C. S. Herrington, P. S. Moore, and T. F. Schulz. 1997. The 222-to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J. Virol. 71:5915-5921.
57. Rothe, M., M.-G. Pan, W. J. Henzel, T. M. Ayres, and D. Goeddel. 1995. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83:1243-1252.
58. Russo, J. J., R. A. Bohenzky, M.-C. Chien, J. Chen, M. Yan, D. Maddalena, J. P. Parry, D. Peruzzi, I. S. Edelman, Y. Chang, and P. S. Moore. 1996. Nucleotide sequence of Kaposi's sarcoma-associated herpesvirus (HHV 8). Proc. Natl. Acad. Sci. USA 93:14862-14868.
59. Sample, J., D. Liebowitz, and E. Kieff. 1989. Two related Epstein-Barr virus membrane proteins are encoded by separate genes. J. Virol. 63:2743-2753.
60. Sarid, R., O. Flore, R. A. Bohenzky, Y. Chang, and P. S. Moore, 1998. Transcriptional mapping of the Kaposi's sarcoma-associated herpesvirus (KSHV) genome in the body cavity-based lymphoma cell line BC-1. J. Virol. 72:1005-1012.
61. Sato, T., S. Irie, and J. C. Reed. 1995. A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett. 358:113-118.
62. Schulz, T. F., Y. Chang, and P. S. Moore. 1998. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8), p. 87-134. In D. J. McCance (ed.), Human tumor viruses. ASM Press, Washington, D.C.
63. Simpson, G. R., T. F. Schulz, D. Whitby, P. M. Cook, C. Boshoff, L. Rainbow, M. R. Howard, S.-J. Gao, R. A. Bohenzky, P. Simmonds, C. Lee, A. de Ruiter, A. Hatzakis, R. S. Tedder, I. V. D. Weller, R. A. Weiss, and P. S. Moore. 1996. Prevalence of Kaposi's sarcoma-associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 348:1133-1138.
64. + T cells. J. Infect. Dis. 176:541.
65. Songyang, Z., S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, B. G. Neel, R. B. Birge, J. E. Fajardo, M. M. Chou, H. Hanafusa, B. Schaffhausen, and L. C. Cantley. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778.
66. Songyang, Z., S. E. Shoelson, J. McGlade, P. Olivier, T. Pawson, X. R. Bustelo, M. Barbacid, H. Sabe, H. Hanafusa, T. Yi, R. Ren, D. Baltimore, S. Ratnofsky, R. A. Feldman, and L. C. Cantley. 1994. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk and Vav. Mol. Cell. Biol. 14:2777-2785.
67. Soulier, J., L. Grollet, E. Oskenhendler, P. Cacoub, D. Cazals-Hatem, P. Babinet, M.-F. d'Agay, J.-P. Clauvel, M. Raphael, L. Degos, and F. Sigaux. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276-1280.
68. Staskus, K. A., W. Zhong, K. Gebhard, B. Herndier, H. Wang, R. Renne, J. Beneke, J. Pudney, D. J. Anderson, D. Ganem, and A. T. Haase. 1997. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J. Virol. 71:715-719.
69. Stūrzl, M., C. Blasig, A. Schreier, F. Neipel, C. Hohenadl, E. Cornali, G. Ascherl, S. Essner, N. H. Brockmeyer, M. Ekman, E. E. Kaaya, E. P. Tschachler, and P. Biberfeld. 1997. Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma (KS). Int. J. Cancer 72:68-71.
70. Stürzl, M., A. Schreier, C. Blasig, C. Zietz, B. Ensoli, P. J. Browning, F. Neipel, and P. Biberfeld. 1997. Human herpesvirus 8 (HHV-8) gene expression in Kaposi's sarcoma (KS) lesions: an in situ hybridization study. J. Mol. Med. 75:B185. (Abstract 117.)
71. Tomkinson, B., and E. Kieff. 1992. Use of second site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein EBNA-3B is not important for B lymphocyte infection or growth transformation in vitro. J. Virol. 66:2893-2903.
72. Tomkinson, B., E. Robertson, and E. Kieff. 1993. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol. 66:2893-2903.
73. Wang, D., D. Liebowitz, and E. Kieff. 1985. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840.
74. Whitby, D., M. Luppi, P. Barozzi, C. Boshoff, R. A. Weiss, and G. Torelli. 1998. Human herpesvirus 8 seroprevalence in blood donors and patients with lymphoma from different regions of Italy. J. Natl. Cancer Inst. 90:395-397.
75. Zhong, W., H. Wang, B. Herndier, and D. Ganem. 1996. Restricted expression of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi's sarcoma. Proc. Natl. Acad. Sci. USA 93:6641-6646.
76. Zong, J.-C., C. Metroka, M. S. Reitz, J. Nicholas, and G. S. Hayward. 1997. Strain variability among Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genomes: evidence that a large cohort of United States AIDS patients may have been infected by a single common isolate. J. Virol. 71: 2505-2511.